VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ORKA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ORKAOruka Therapeutics, Inc.
$95.74$5.8B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksORKAQuarterly Financials

Oruka Therapeutics, Inc. (ORKA) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Oruka Therapeutics, Inc. (ORKA) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ORKA Income Statement

Quarterly statement

ORKA Income Statement

Oruka Therapeutics, Inc. (ORKA) annual income statement — 21-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q3'20Q2'20
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold49K43K43K28K00000019K23K28K28K27K19K17K16K26K26K
COGS % of Revenue--------------------
Gross Profit-49K-43K-43K-28K000000-19K-23K-28K-28K-27K-19K-17K-16K-26K-26K
Gross Margin %--------------------
Gross Profit Growth %------100%100%-----64.71%-75%-3.85%26.92%32%33.33%-18.18%-18.18%
Operating Expenses62.09M50.06M36.39M34.4M34.1M28.43M25.09M38.33M29.45M21.49M2.46M1.57M3.25M5.65M4.69M4.82M4.08M5.11M1.96M1.28M
OpEx % of Revenue--------------------
Selling, General & Admin8.44M6.81M7.25M6.76M5.12M4.34M5.16M6M3.76M2.82M1.67M1.52M1.07M1.71M1.25M1.24M1.21M1.91M913K912K
SG&A % of Revenue--------------------
Research & Development53.7M43.26M29.14M27.64M28.99M24.09M19.93M32.33M25.69M18.67M165K47K2.18M3.94M3.44M3.58M2.88M3.2M1.05M372K
R&D % of Revenue--------------------
Other Operating Expenses-49K000000000628K000000000
Operating Income-62.14M-50.11M-36.43M-34.43M-34.1M-28.43M-25.09M-38.33M-29.45M-21.49M-2.48M-1.59M-3.28M-5.68M-4.72M-4.84M-4.1M-5.13M-1.99M-1.31M
Operating Margin %--------------------
Operating Income Growth %-82.19%-76.25%-45.24%10.17%-15.81%-32.27%-910.72%-2310.64%----20.11%-10.81%-136.98%-269.24%-206.12%-301.1%-59.58%13.13%
EBITDA-62.09M-50.06M-36.39M-34.4M-34.09M-28.41M-25.07M-38.31M-28.12M-21.48M4.38M-1.57M-3.25M-5.65M-4.69M-4.82M-4.08M-5.11M-1.96M-1.28M
EBITDA Margin %--------------------
EBITDA Growth %-82.15%-76.22%-45.16%10.21%-21.22%-32.26%-672.24%-2345%----20.47%-10.61%-138.75%-275.23%-210.65%-307.5%-60.33%13.59%
D&A (Non-Cash Add-back)49K43K43K28K20K19K16K16K012K6.86M23K28K28K27K19K17K16K26K26K
EBIT-62.13M-50.11M-31.82M-29.58M-30.28M-24.57M-21M-37.46M-28.12M-22.24M-2.01M-1.09M-3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.31M
Net Interest Income12.17M8.9M4.61M4.85M3.83M3.86M4.09M4.53M826K444K473K501K000000-2K-3K
Interest Income12.17M8.9M4.61M4.85M3.83M3.86M4.09M4.53M1.33M444K473K501K00000000
Interest Expense00000000504K0000000002K3K
Other Income/Expense12.17M8.9M4.61M4.85M3.83M3.85M4.09M4.94M826K-750K473K501K5K4K4K3K2K1K-1K-1K
Pretax Income-49.97M-41.21M-31.82M-29.58M-30.28M-24.57M-21M-33.39M-28.62M-22.24M-2.01M-1.09M-3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.31M
Pretax Margin %--------------------
Income Tax0000000000000000000-9K
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0.69%
Net Income-49.97M-41.21M-31.82M-29.58M-30.28M-24.57M-21M-33.39M-28.62M-22.24M-2.01M-1.09M-3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.3M
Net Margin %--------------------
Net Income Growth %-65.03%-67.68%-51.53%11.41%-5.78%-10.48%-945.25%-2966.32%----20.2%-10.75%-136.66%-271.28%-210.61%-318.03%-72.23%9.33%
Net Income (Continuing)-49.97M-41.21M-31.82M-29.58M-30.28M-24.57M-21M-33.39M-28.62M-22.24M-2.01M-1.09M-3.27M-5.68M-4.71M-4.83M-4.1M-5.13M-1.99M-1.3M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.63-0.66-0.58-0.54-0.69-0.58-0.50-1.54-1.91-1.30-0.24-0.90-2.72-4.73-3.92-4.03-3.98-6.44-3.95-8.71
EPS Growth %8.7%-13.79%-16%64.94%63.87%55.38%-108.33%-71.11%----31.66%26.55%0.76%53.73%59.96%30.23%56.69%36.14%
EPS (Basic)-0.63-0.66-0.58-0.54-0.69-0.58-0.50-1.54-1.91-1.30-0.24-0.90-2.72-4.73-3.92-4.03-3.98-6.44-3.95-8.71
Diluted Shares Outstanding71.59M62.87M55.17M54.42M44.07M42.23M41.68M16.79M15.01M14.51M14.5M14.42M1.2M1.2M1.2M1.2M1.03M795.68K503.69K149.49K
Basic Shares Outstanding71.59M62.87M55.17M54.42M44.07M42.23M41.68M16.79M15.01M14.51M14.5M14.42M1.2M1.2M1.2M1.2M1.03M795.68K503.69K149.49K
Dividend Payout Ratio--------------------